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Optimal Mass Transport with
Lagrangian Workflow Reveals
Advective and Diffusion Driven
Solute Transport in the Glymphatic
System
Sunil Kounda1,7, Rena Elkin2,7, Saad Nadeem3, Yuechuan Xue1, Stefan Constantinou1,
Simon Sanggaard1, Xiaodan Liu1, Brittany Monte1, Feng Xu4, William Van Nostrand4,
Maiken Nedergaard5, Hedok Lee1, Joanna Wardlaw 6, Helene Benveniste1,8 &
Allen Tannenbaum2,8*
The glymphatic system (GS) hypothesis states that advective driven cerebrospinal fluid (CSF) influx
from the perivascular spaces into the interstitial fluid space rapidly transport solutes and clear waste
from brain. However, the presence of advection in neuropil is contested and solutes are claimed to be
transported by diffusion only. To address this controversy, we implemented a regularized version of the
optimal mass transport (rOMT) problem, wherein the advection/diffusion equation is the only a priori
assumption required. rOMT analysis with a Lagrangian perspective of GS transport revealed that solute
speed was faster in CSF compared to grey and white matter. Further, rOMT analysis also demonstrated
2-fold differences in regional solute speed within the brain. Collectively, these results imply that
advective transport dominates in CSF while diffusion and advection both contribute to GS transport in
parenchyma. In a rat model of cerebral small vessel disease (cSVD), solute transport in the perivascular
spaces (PVS) and PVS-to-tissue transfer was slower compared to normal rats. Thus, the analytical
framework of rOMT provides novel insights in the local dynamics of GS transport that may have
implications for neurodegenerative diseases. Future studies should apply the rOMT analysis approach
to confirm GS transport reductions in humans with cSVD.
The glymphatic system is described as a perivascular transit passageway for cerebrospinal fluid (CSF) for
exchange with interstitial fluid (ISF), thereby facilitating waste drainage from the brain1,2. Investigations of glymphatic system (GS) function have escalated given its important role in Aβ1 and tau3 clearance from brain and the
inferred implication for neurodegeneration, including Alzheimer’s disease2,4–7. The GS is made up by the perivascular spaces (PVS), which connect with ISF via the aquaporin 4 (AQP4) water channels on astrocytic end-feet
and through the small gaps between the overlapping astrocytic end-foot processes1. The GS hypothesis states
that advective CSF influx from the PVS rapidly drives interstitial solutes and waste products out via peri-venous
channels1,8. Although solute transport in the PVS along pial arteries on the surface of the brain is advective (bulk
flow) and driven by cardiac pulsatility1,9–11, the presence of advective streams in parenchyma12–14 is contested with
the argument that advection does not occur in the neuropil and solutes are transported by diffusion only15–21. No
1

Department of Anesthesiology, Yale School of Medicine, New Haven, CT, USA. 2Departments of Computer Science/
Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, USA. 3Department of Medical
Physics, Memorial Sloan Kettering Cancer Center, NY, NY, USA. 4George & Anne Ryan Institute for Neuroscience,
Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Rhode Island, RI, USA. 5Center
for Translational Neuromedicine, University of Rochester Medical Center, Rochester, NY, USA. 6Brain Research
Imaging Centre, Centre for Clinical Brain Sciences, Dementia Research Institute at the University of Edinburgh,
Edinburgh, United Kingdom. 7These authors contributed equally: Sunil Kounda and Rena Elkin. 8These authors
jointly supervised this work: Helene Benveniste and Allen Tannenbaum. *email: allen.tannenbaum@stonybrook.edu
Scientific Reports |

(2020) 10:1990 | https://doi.org/10.1038/s41598-020-59045-9

1

www.nature.com/scientificreports/

www.nature.com/scientificreports

single study has unequivocally determined which mode of solute transport prevails inside the brain proper. This
gap in knowledge has significantly impeded exploration of the GS and has raised questions regarding its importance for brain health, disease, and its potential as a therapeutic target against neurodegeneration.
Recently, various computational analyses and simulations have been performed to better understand the driving mechanisms of solute transport across PVS boundaries and through ISF space22–24. Conservation principles
are typically used to derive these simulations, a popular one being the porous media model25–27. Ray et al.28 proposed adding an advection term to the (diffusive) porous media model and their simulations involving molecules
such as Aβ indicated the presence of advective transport in the ISF. Simulations are very effective for distinguishing between advection and diffusion, but when applied in vivo, inferable insight becomes limited. The key reason
for this problem lies in the fact that modeling in live brain requires accurate delineation of anatomical boundaries
and knowledge of various kinematic parameters, many of which are unknown.
To provide local dynamic analysis and inform on GS transport modes across compartments in the live brain
we now introduce novel computational methods for studies based on dynamic contrast enhanced magnetic resonance imaging (DCE-MRI)8,29,30. Specifically, we implemented techniques from the theory of optimal mass
transport (OMT)31–33. The OMT theory is centuries old and has impacted many topics of research in the physical
sciences, economics, computer science and image processing31,34–36. Given initial and final mass distributions,
OMT provides a powerful dynamic computational fluid formulation that gives an optimal interpolation path of
minimal energy among all possible interpolations that preserve mass37. In this way, OMT can be formulated as
a variational problem based on the principle of least action. A particularly attractive feature of OMT is that one
obtains unique solutions to the model, not by imposing smoothness, but rather by seeking flows that minimize
the expended transport energy. In the classical formulation of OMT, the continuity equation involves advection
only. Considering that diffusion is assumed to be always occurring in the brain, we have added a diffusion term
in the work presented here. We refer to our modified OMT formulation with the advection/diffusion equation
as the regularized OMT problem (rOMT). We utilized an associated Lagrangian formulation of rOMT for the
construction of ‘pathlines’ to effectively extract and visualize GS transport flows over a predetermined set of time
frames in one comprehensive figure. Time-varying particle (a.k.a. solute) attributes associated with the pathlines,
such as ‘speed’ were also computed.
Here we apply our new rOMT formulation to address three overarching and unresolved questions: 1) Can we
confirm the existence of the two types of transport (diffusion and advection) in the different GS compartments?
2) Can we obtain voxel-level information on solute transport across all tissue compartments, circumventing the
problem of varying GS transport kinetics and avoiding the need to specify all of the material properties for simulations? and 3) Given that GS dysfunction is reported in neurodegeneration particularly where vascular dysfunction may be involved7,38,39, can our rOMT framework dissect different modes of solute transport in an animal
model of cerebral small vessel disease?

Results

Introducing rOMT for tracking advection and diffusion modes of GS transport. GS transport was

measured in live rats using DCE-MRI and administration of gadoteric acid (Gd-DOTA) into CSF via the cisterna
magna29,30,40. The DCE-MRI rat brain data were input into the rOMT framework for dissecting GS transport
modes of the Gd-DOTA solute. The rOMT formulation with the inclusion of both advection and diffusion terms
in the constraint (continuity) equation is described in detail in Methods. Here we highlight that the Lagrangian
formulation was used to construct dynamic ‘pathlines’ for visualizing GS transport flows in one comprehensive
figure, derived from the rOMT returned velocity field and interpolated images (Methods and Fig. 1). As such,
a Lagrangian pathline traces the trajectory of a specific particle over a pre-defined time interval. A particle may
refer to a parcel of mass or an individual substance. For our purposes, we use particle interchangeably with solute.
Observations of particle attributes, such as speed, are made from the vantage point of the particular particle as it
traverses its trajectory. In this way, ‘pathlines’ and ‘speed-lines’ encapsulate the moving particle dynamics in the
GS network in a single entity. Additional information, such as flow volume (size of the pathline network), reflecting the total flux of moving particles, is extracted and used in the following for analyzing GS transport across
tissue compartments and brain regions. For ease of narration, we refer to the extraction and visualization of the
Lagrangian representation of Glymphatic Dynamics as our GLaD framework (Fig. 1). rOMT as well as GLaD
analysis was performed on DCE-MRI images taken over the 120 min interval starting at the time of peak signal
(Fig. 1a). This time interval afforded the best representation of GS transport because the signal-to-noise ratio
(peak) and redistribution of Gd-DOTA tracer into brain parenchyma is maximized.
Note also that the rOMT algorithm captures the Fick’s law aspect of the flow model, namely the diffusion
mode of particle transport controlled by the gradient of the concentration. This was accomplished using a custom
built ‘diffusion’ phantom incorporating the microdialysis technique41 (Supplementary Fig. 1 and Movie 1). The
rOMT model was applied to the DCE-MRI data acquired in the diffusion phantom. Knowing that the solute
transport in the phantom was uniquely diffusive, we examined how our model performed if we forced fictitious
advective transport. This was done by using very low diffusivity values that were intentionally insufficient to
mimic the diffusing intensity patterns observed in DCE-MRI acquired in the phantom. This numerical intervention thereby forced advection to compensate for the lack of diffusion in the modeling of interpolated images.
Although the advective and diffusive fluxes influence each other (see Methods), the advective flux is primarily
influenced by time-varying changes in voxel intensity while the diffusive flux is primarily influenced by spatial
variations. Attempting to account for both temporal and spatial changes in intensity with advection alone resulted
in an irregular flow field in the interpolated images. Therefore, it was not surprising that efforts to extract meaningful (smooth) pathlines with our aforementioned GLaD framework failed on the phantom data under these
conditions.
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Figure 1. Processing steps for rOMT Lagrangian Glymphatic System transport flow derivatives. Illustration
of the regularized optimal mass transport (rOMT) and Lagrangian representation of Glymphatics Dynamics
(GLaD) pipeline for visualizing transport flows (a) DCE-MRIs over a 120 min experimental window (50–
160 min) were fed as inputs into the rOMT model (b) The model returns the interpolated density images and
velocity fields which are (c) subsequently processed by our GLaD visualization framework. (d) Advective and
diffusive glymphatic system transport is expressed by the pathlines captured in the Lagrangian analysis with
corresponding dynamic speedlines. Binary pathlines were used to extract flow volume and speedlines were
used to assess spatial distribution of speed trajectories in whole brain as well as to derive mean speed values.
(e) Thereafter, compartmental analysis is carried out based on tissue masks derived from the morphometric
analysis.

Next, we repeated the rOMT model on the DCE-MRI diffusion phantom data, but this time with an appropriate diffusivity value (experimentally determined). The resulting flow field was governed by the diffusive flux,
as expected. As shown (Supplementary Movie 1), diffusive flux vectors point from voxels with higher intensity
toward voxels with lower intensity and there is near-perfect consistency between the acquired DCE-MRI images
(Fig. 2a) and the returned interpolated model images (Fig. 2b). This numerical experiment proved informative
for understanding the advantages of adding the diffusion term to the classical dynamic OMT formulation, and
the roles of each transport mode (see Methods).

Diffusion and advection are both required for rOMT modeled images to match in vivo
images. Adding diffusion in the rOMT model was required for matching GS transport patterns observed in

the live rat brain by DCE-MRI (Fig. 2c) with the modelled rOMT images (Fig. 2d–fs). To choose an appropriate diffusivity value, we tested multiple values and examined how the flow fields changed. Specifically, we computed streamlines from the rOMT derived velocity fields at each time step along with the corresponding speeds.
Streamlines are curves that are tangent to the velocity field at a fixed time, informing on the collective instantaneous behavior of the flow. We chose this approach over the GLaD-pathline analysis to investigate the ‘smoothness’
of the flow field at individual time steps, which should be directly affected by diffusion. A representative example
of speed (color-coded) from a normal Wistar Kyoto (WKY) rat associated with streamlines is shown in Fig. 2d–f,
illustrating the effect of increasing the strength of the diffusion term ‘σ2’ in the rOMT algorithm. With either
no diffusion (Fig. 2d) or too much diffusion (Fig. 2f), the captured behavior in the CSF compartment is erroneously overactive while information about the flow in the deeper regions, where parenchymal transport of interest occurs, is altogether unrealized. We determined that an intermediate amount of diffusion (σ2 = 0.002) was
required (Fig. 2e) to best replicate observed GS transport in both peripheral and central regions (see the Methods
section for a more detailed discussion). This led us to conclude that parenchymal GS transport is governed by
both advection and diffusion. However, it is important to emphasize that parenchymal GS transport of the extracellular tracer, Gd-DOTA captured within a given DCE-MRI defined voxel (e.g., range of 0.003–0.027 mm3) represents transport within an ISF compartment of 18–22%42,43 in addition to the PVS spaces. The volume fraction of
(abnormally) enlarged PVS by MRI is reported in the range of ~2–3% in the basal ganglia of human brain44 and
we therefore estimate the PVS volume fraction in normal rodent brain to be of the order of 1% or less.
We should note that the speed pathlines do not address the issue of ‘concentration’ and over the time window,
there will be declining contrast in both compartments. We are not assuming that the concentration is the same in
the two compartments when we apply the algorithm to the data. The data in its current form does not allow us to
distinguish concentrations. Further, when we implement the mathematical algorithm, the contrast of the images
is normalized so that the total contrast (sum of the intensities) is the same, even though locally there are of course
changes. We are now working on employing an unbalanced version of the algorithm36, for which the normalization (nor any assumption of mass preservation) will be necessary.
We also note that future work will entail improvements in the diffusion model. At the current stage of method
development, we have chosen the σ2 value empirically based on ‘best’ match of simulated rOMT data to raw
DCE-MRI data. We plan to train our method on a number of GS transport samples and then use standard
Scientific Reports |
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Figure 2. Diffusion is required for rOMT model data to capture glymphatic transport patterns. (a) Agar
distribution after ~ 2 hrs of diffusion, as captured with contrast-enhanced MRI, is shown in grayscale. The
diffusive direction, proportional to the negative of the image gradient, is shown by the green arrows. (b) The
corresponding rOMT-returned image is shown in grayscale with diffusive flux vectors characterizing the flow
behavior and in alignment with Fick’s law are overlaid in green for comparison to ‘ground truth’ (a). (c) Whole
brain % signal from baseline at 100 min after contrast injection is shown for context. Corresponding colorcoded flow speeds along streamlines computed from the rOMT-derived vector field associated with 100 min
after contrast injection for multiple diffusion levels are compared, illustrating how an appropriate diffusion
value was selected. (d) With no diffusion, the flow shows exaggerated peripheral advective behavior and central
parenchymal transport is unaccounted for. (e) Using moderate but sufficient diffusion yields feasible peripheral
behavior and accounts for transport in deeper parenchymal regions. (f) With high diffusion, more activity is
accounted for but exaggerated peripheral behavior is also seen.

machine learning techniques to design a more automatic method for tuning σ2 as well as consider possible spatially dependent diffusion covariance matrices.

Solute speed varies across tissue compartments in normal and hypertensive rats. To derive GS

solute transport across tissue compartments at the voxel-level, we applied the proposed rOMT + GLaD analytical
pipeline to segmented whole brain DCE-MRIs acquired in normotensive WKY rats and in spontaneously hypertensive stroke prone (SHRSP) rats (Methods). The SHRSP rat is a naturally bred animal which mimics human
hypertension and associated cerebral small vessel disease (cSVD)45. Examples of pathlines (color-coded for speed)
derived in CSF, WM and grey matter (GM) compartments from a WKY and a SHRSP rat are shown in Fig. 3a–c.
Anatomically, pathlines in GM were more prominent in the cerebellum, hippocampus and hypothalamus of
WKY rats (Fig. 3b). In WM of WKY rats, pathlines dominated in the brainstem and midbrain (Fig. 3b). In SHRSP
rats, subarachnoid CSF pathlines showed overall more heterogeneous distribution and were most prominent
ventrally (Fig. 3c, top). In WKY rats, total pathline volume in the CSF compartment (representing the total flux
of ‘moving’ solutes in CSF over 120 min) was 20% higher when compared to SHRSP rats (7124 ± 605 voxels vs
5822 ± 636 voxels, p = 0.001, Mann-Whitney, Fig. 3d), suggesting restricted CSF transport in SHRSP compared
to WKY rats. In SHRSP rats, the lower than normal CSF pathline volume was associated with reduced pathline
volume in both GM and WM compartments when compared to WKY rats (Fig. 3d), signifying overall decreased
GS transport in SHRSP rats. In the corpus callosum, pathline volume was variable with a trend towards decreased
solute transport in the SHRSP compared to WKY rats (582 ± 236 vs 330 ± 120, p = 0.051, Mann Whitney).
We next analyzed the time-varying particle attributes associated with the pathlines, that is, ‘speed’ given by
the magnitude of the transport vectors derived by the rOMT + GLaD procedure (Fig. 1). Speed trajectories of
the pathlines are displayed as color-coded maps for each tissue compartment (Fig. 3b,c). In WKY rats, fast speed
(red color) was evident in the CSF subarachnoid compartment on the ventral surface of the brain, superficial to
the cerebellum and cerebral cortex (Fig. 3b, top). Slower (blue color) speed trajectories were observed inside the
cerebral ventricles (Fig. 3b top). In WKY and SHRSP rats, mean pathline speed was ~40% faster in CSF when
compared to the GM and WM compartments (Fig. 3e). Mean pathline speed in CSF of SHRSP rats was within a
similar range to those of WKY rats (0.10 ± 0.026 versus 0.09 ± 0.02, p = 0.558) and no differences in mean speed
were observed in GM and WM compartments between the two strains. We also compared directional tracer
movement from CSF into the tissue compartment between WKY and SHRSP rats (Supplementary Fig. 2). Using
the rOMT-derived velocity field, we evaluated the total (advective + diffusive) flux across this surface with attention to the net mass moving from the CSF compartment into the tissue compartment. This analysis showed that
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Figure 3. rOMT whole brain analysis reveals varying solute speed across tissue compartments. (a)
Cerebrospinal fluid (CSF), grey matter (GM) and white matter (WM) masks overlaid on the brain anatomical
template to illustrate the spatial distribution of the brain tissue compartments used for the rOMT analysis. (b)
Pathlines - color-coded to denote speed - overlaid on corresponding anatomical brains are shown from a WKY
rat in CSF, WM and GM compartments. Red and blue colored pathlines denote fast and slow pathline speeds,
respectively. In the CSF compartment, pathlines are fast moving at the ventral surface. Pathlines with slower
speed lines can be seen inside the cerebral ventricles (cVtr). Speed pathlines in GM and WM compartments
are variable: faster speed in the periphery and slower speed profiles as they penetrate into deeper parts of
parenchyma. CTX = cortex; CB = cerebellum; Hip = hippocampus; HT = hypothalmus; MB = midbrain;
BS = brain stem. (c) Corresponding pathlines in the three tissue compartments from a SHRSP rat are shown.
It is clear that pathlines in CSF are sparser and more heterogeneously distributed in the SHRSP rat when
compared to the WKY rat. For example, there are no pathlines above cortex and very few superficial to the
cerebellum. For SHRSP, there are also less pathlines in the GM and WM, as compared to the WKY rat. (d)
Analysis of the total flux of solutes in the pathline network (number of voxels) revealed decreases in all three
compartments in SHRSP when compared to WKY rats. (e) In both WKY and SHRSP strains, mean pathline
speed in CSF was significantly faster than mean pathline speed in the WM compartment. Data are mean ± SD.
Mann-Whitney’s test was used for cross-strain analysis. Friedman’s ANOVA was used for within-strain regional
analysis. *significant at level alpha = 0.05.
the average net mass transported into the tissue compartment was significantly higher for WKY when compared
to SHRSP rats (Supplementary Fig. 2).

Solute speed varies across brain regions. We next considered regional GS transport using GLaD analysis applied to DCE-MRI data extracted from pre-selected brain regions distributed in the GS network including
the hippocampus, cerebellum, superior colliculus and basal forebrain regions (Fig. 4a). Using the same visualization scheme as for the whole brain data, Fig. 4 shows pathlines color-coded for speed captured inside cerebellum, superior colliculus, hippocampus and basal forebrain from a representative WKY (Fig. 4b) and SHRSP rat
(Fig. 4c). In the SHRSP rats, the total volume of pathlines was significantly reduced in the cerebellum, hippocampus and superior colliculus when compared to WKY rats (Fig. 4d). Furthermore, GS transport varied across brain
regions as evidenced by the varying distribution of pathlines across the brain in both strains. In the SHRSP rats,
pathlines were sparser in the hippocampus compared to the basal forebrain (Fig. 4d). For both WKY and SHRSP
rats, it was evident that pathline speed was not uniform across regions (Fig. 4e). Within normotensive WKY rats,
mean pathline speed in the basal forebrain region was significantly increased when compared to the hippocampus
(0.102 ± 0.025 vs 0.055 ± 0.016, p = 0.006, Friedman test) and superior colliculus (0.102 ± 0.025 vs 0.053 ± 0.012,
p = 0.021, Friedman test). Within the SHRSP rats, mean pathline speed also varied significantly across regions
(Fig. 4f). Across strains, the analysis revealed that mean speed in the superior colliculus was significantly reduced
in the SHRSP when compared to WKY rats (0.053 ± 0.012 vs 0.040 ± 0.005, p = 0.022, Mann Whitney).
Solute transfer from PVS-to-tissue is impaired in hypertensive SHRSP rats.

To further explore
GS solute transport dynamics between the two strains, we acquired DCE-MRIs at higher spatial resolution using
a smaller 1-cm RF-surface coil positioned above the left hemisphere of the rat’s head to capture transport in the
PVS of pial arteries at the circle of Willis and along the entire middle cerebral artery (MCA) of the left hemisphere
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Figure 4. Solute speed is not uniform across brain regions. (a) Volume rendered anatomical delineation of
brain regions including the cerebellum (Cb), superior colliculus (Sc), hippocampus (Hip) and basal forebrain
(Bf) that were used for the analysis. Top and lateral views of the regions are shown. (b) Color-coded pathlines
depicting speed captured over 120 min are shown from a normal WKY rats inside the regions of interest. In
the normal WKY rat, speed trajectories in the cerebellum penetrate the entire region. Pathlines at the level of
the dorsal hippocampus are sparser when compared to the ventral hippocampus. (c) Color-coded pathlines
depicting speed captured over 120 min are shown from a SHRSP rat for the same regions. Note that in this
particular SHRSP rat, pathlines barely reach the superior colliculus and are not observed in the center of the
cerebellum. (d) The total pathline volume for each region was calculated and compared between WKY and
SHRSP rats. Except for the Bf, all regions showed lower pathline volume in SHRSP when compared to WKY
rats. (e) Mean pathline speed varied across brain regions in both strains. The fastest mean speed was observed in
the basal forebrain for both strains. Data are mean ± SD. Mann-Whitney’s test was used for cross-strain analysis.
Friedman’s ANOVA was used for within-strain regional analysis. *Significant at level alpha = 0.05.

(Movie 2). To boost signal-to-noise ratio in the PVS, we administered 20 µL of 1:5 Gd-DOTA diluted with sterile
water at a rate of 1.5 µL/min into the CSF. The higher Gd-DOTA levels in CSF enabled us to track solute transport
along the entire left hemispheric MCA at a voxel resolution of 0.15 × 0.15 × 0.15 mm3. We first extracted time
signal curves (TSC) from the PVS along the MCA on the ventral surface (a.k.a. ‘MCA-PVS root’, Fig. 5a) and
observed strikingly different signal dynamics between SHRSP and WKY rats (Fig. 5b). While the MCA-PVS
root TSCs from SHRSP and WKY rats were characterized by similar time-to-peak and peak magnitude, the
signal ‘relaxation’ phase was faster in WKY rats, suggesting faster transit of solutes into parenchyma compared
to SHRSP rats (Fig. 5b). This interpretation was supported when comparing DCE-MRIs at the base of the brain
after ~3 hrs of CSF Gd-DOTA circulation (Fig. 5c,d): Significantly higher Gd-DOTA signal was evident along the
root PVS-MCA of SHRSP rats (Fig. 5d) but not along the MCA distal to this point when compared to WKY rats
(Fig. 5e), suggestive of physical obstruction (or ‘slow-down’) of MCA-PVS flow in this area.
The rOMT + GLaD pipeline was applied to extract pathline speed information along the MCA. Pathline start
points were selected from binary masks capturing tissue along the MCA in order to analyze transport behavior
stemming from this specific region (see Methods). The color-coded speed maps along the MCA were overlaid
on the anatomical MRIs of the left hemisphere (Fig. 5e,f). While pathline speed appeared to be homogeneous
along the MCA in WKY rats (Fig. 5e), pathline speed varied along the MCA in SHRSP rats (Fig. 5f). Specifically,
in SHRSP rats, pathline speed was increased by 3-fold along the MCA ‘root’ when compared to speed along the
MCA distal to this area (0.12 ± 0.04 vs 0.04 ± 0.01, p = 0.029, Student’s t test). Corresponding measurements in
WKY rats did not reveal significant differences in speed along the MCA (p = 0.25). We also noted that in WKY
pathlines had migrated >4 mm away from the MCA-PVS into the adjacent tissue (Fig. 5e). In contrast, in SHRSP
rats, pathlines were observed in closer proximity to the PVS-MCA indicating slower transfer of solutes into the
ISF (Fig. 5f).
We also performed directional analysis of the advective flux direction along the MCA in WKY rats (Fig. 6).
Advective flux vectors were calculated across the boundaries of the binary mask created along the MCA from the
rOMT output. Figure 6 shows advective flux vectors (normalized to have unit length) along the MCA overlaid on
corresponding anatomical MRI templates from WKY (Fig. 6a,b) and SHRSP (Fig. 6c,d) rats. Fig. 6a–d highlight
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Figure 5. Solute transfer from the perivascular space (PVS) along the middle cerebral artery. (a) Contrast
enhanced MRIs from a WKY rat at the level of the circle of Willis near the take-off of the middle cerebral artery
(MCA). Contrast in the perivascular space along the circle of Willis and MCA is evidenced as a high intensity
signal along the vasculature, which is black. Regions of interest along the MCA (white lines) were used to
capture time signal curves (TSC) from the dynamic contrast enhanced MRIs acquired in WKY and SHRSP
rats. (b) Mean TSC extracted from WKY (N = 4) and SHRSP (N = 4) rats along the first segment of the MCA
(‘root’) are displayed. Data are mean ± SD. It is evident that while ‘time-to-peak’ and peak magnitude are within
same range for the two strains, the signal decline (representing redistribution of contrast from PVS to tissue
and tissue clearance) is strikingly faster in WKY when compared to SHRSP rats. (c) Volume-rendered, colorcoded signal map after ~180 min of circulation of CSF contrast in a WKY rat overlaid onto the corresponding
anatomical template. High and low contrast signal amplitude is given by red and blue colors respectively.
Contrast is observed along the entire MCA during its trajectory across the left hemisphere. (d) Corresponding
color-coded signal map from a SHRSP rat showing much higher levels (red color) of contrast in the PVS along
the circle of Willis and along the MCA root. Heterogeneously distributed contrast along the MCA is more
evident in the SHRSP when compared to WKY rat. (e,f) The color-coded speed maps along the MCA are
overlaid on the anatomical volume rendered MRIs of the left hemisphere of a WKY (e) and SHRSP (f). While
pathline speed appeared to be homogeneous along the MCA in WKY rats, pathline speed in SHRSP rats was
high in areas localized to the ‘root’ area and lower distal to this point.
directions of the advective flux vectors from the ventral surface of the brain at the level of the circle of Willis
from where the MCA takes off (white boxes in Fig. 6a,c). In the WKY rat the advective flux vectors’ direction is
following the path along the MCA in a congruent pattern (Fig. 6a,b). However, in the SHRSP rat, the advective
flux vectors are following the direction of the MCA only part of the way. Specifically, at the inflection point where
the MCA change direction the advective flux vectors deviate from the PVS along the MCA (Fig. 6c,d). These
deflections in advective flux vector directions along the MCA in SHRSP compared to WKY rats is also clearly
appreciated in caudal projection views (Fig. 6e,f).

Mechanisms underlying the decreased GS transport in SHRSP compared to WKY rats. We next
explored major drivers of GS transport to uncover possible mechanisms underlying the differences observed
between SHRSP and WKY rats. Increases9 and decreases1,10 in vascular pulsatility have been shown to accelerate and decelerate GS influx, respectively. Only subtle differential effects of rat strain on the mean heart rate
recorded continuously during the glymphatics MRI experiments were noted (Supplementary Table 1). In fact,
mean heart rate was slightly increased in SHRSP compared to WKY rats, leading us to conclude that changes in
heart rate were unlikely to contribute to GS transport impairment observed in the SHRSP rats. In a series of randomly selected awake, non-anesthetized rats from age-matched cohorts of WKY and SHRSP rats, non-invasive
blood pressure was measured using the tail-cuff method. Systolic and pulse pressures were significantly higher in
SHRSP compared to WKY rats (Supplementary Table 1). Anesthesia generally lowers blood pressure when compared to the awake state and the anesthetized SHRSP rats used for the glymphatics experiments might therefore
not have been hypertensive. Thus, in a separate series of rats with femoral artery catheterization, we documented
that mean arterial blood pressure indeed remained higher in SHRSP rats, even under anesthesia, when compared
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Figure 6. Advective flux vectors along the MCA show aberrant flow in SHRSP. (a,b) Advective flux vectors
across the boundary along the MCA, determined from the binary mask, were calculated from the rOMT output.
The advective flux direction, determined by normalizing the advective flux vectors to have unit length, are
shown overlaid on an anatomical mask of a WKY rat. The ventral surface at the level of the circle of Willis and
MCA origin is highlighted. In the WKY rat, the directions of the advective flux vectors follow the path along
the MCA in a continuous pattern. (c,d) In a corresponding view of a SHRSP rat, the advective flux vectors are
pointing in the same direction along the first segment of the MCA along the ventral surface. However, distal to
this point, the vectors start diverging away from the MCA. (e,f) The deflections in the direction of the advective
flux vectors at the transition from ventral to lateral segments of the MCA in the SHRSP rat compared to the
WKY rat is also clearly visible in ‘caudal’ projection views.

to WKY rats (Supplementary Table 1). Based on these data, we concluded that higher than normal pulse pressures in SHRSP rats might have contributed to the impaired GS transport observed in our study. However, the
anesthetic regimen did lower the blood pressure in the SHRSP rats when compared to non-anesthetized SHRSP
rats, and it is possible that this change in blood pressure might have blunted the pathophysiological consequence
of chronic hypertension on GS transport.
State of arousal46 and type of anesthesia47 have also been shown to affect GS transport. We did not measure electroencephalogram in the experiments, however anesthetic depth was evaluated indirectly by quantifying
anesthetics administered and was found to be similar between strains (Supplementary Table 1). Therefore, we
concluded that differences in depth of anesthesia were unlikely to have contributed to the GS transport alterations
observed.
Polarized perivascular expression of AQP4 water channels has been associated with rapid transport of small
molecular weight solutes from PVS to brain ISF1,39,48. We performed immunohistochemistry on a smaller series
of WKY (N = 4) and SHRSP (N = 4) rats to examine the AQP4 expression patterns associated with small vessels
and capillaries in select brain regions. In WKY rats, the distribution of AQP4 immunofluorescence appeared
homogeneously distributed in the occipital cortex (Fig. 7a) and ventral hippocampus (Fig. 7c). In SHRSP rats,
increased immunofluorescence was noted in patchy areas associated with penetrating cortical and hippocampal
vessels (Fig. 7b,d). AQP4 immunofluorescence intensity was measured along linear ROIs crossing the lumen of
small vessels or cerebral capillaries (separately) and converted into a polarization index (Supplementary Fig. 3
and Methods). The AQP4 polarization index for capillaries was of the same order of magnitude as that of small
vessels. This analysis showed that AQP4 immunofluorescence surrounding the small vessels and capillaries was
more polarized in WKY (higher polarization index) when compared to SHRSP rats (Fig. 7g,h). Further, the
AQP4 polarization index for capillaries in ventral hippocampus of SHRSP rats was significantly lower when
compared to WKY rats (WKY AQP4 polarization index: 2.55 ± 0.08 versus SHRSP AQP4 polarization index:
2.28 ± 0.058, p-value = 0.0079). We also executed qPCR to measure the mRNA expression levels of GFAP and
AQP4 in a separate series of WKY (N = 8) and SHRSP (N = 8) rats in the following regions: cerebellum, cortex,
hippocampus, striatum and thalamus. This analysis revealed no statistical differences in AQP4 or GFAP mRNA
expression between WKY and SHRSP rats (Supplementary Fig. 4). Collectively, based on these data, we conclude
that impaired perivascular AQP4 polarization in SHRSP rats (but not increased total tissue AQP4 expression or
astrogliosis) might have contributed to the reduction in PVS-to-brain solute transfer observed in the SHRSP rats
when compared to WKY rats.
Finally, we explored vascular and structural anatomy at the level of the circle of Willis and area of the MCA
root where GS transport in the PVS along the MCA appeared to be ‘obstructed’. Supplementary Fig. 6 shows
representative brain sections from WKY and SHRSP rats that were immunolabeled with an antibody to collagen
IV to identify cerebral vessels and micro-vessels. In WKY rats, smaller networks of micro-vessels were observed
in distinct areas at the base of the brain surrounding penetrating arteries (Supplementary Fig. 6d–f). However,
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Figure 7. Perivascular AQP4 water channel expression is altered in SHRSP rats. (a) Confocal representative
micrographs show AQP4 immunoreactivity extending from the occipital cortical surface towards the corpus
callosum (CC) and shows that AQP4 was distributed uniformly. (b) Equivalent confocal montage from the
ventral hippocampus of a WKY rat. AQP4 is distributed homogeneously in the Stratum Oriens (Or) and
Stratum Radiatum (SR). (c) AQP4 distribution in occipital cortex from a SHRSP rat showing higher intensity
expression along penetrating vessels (white arrows). (d) In SHRSP rats, intensely expressed AQP4 can be noted
in patchy areas surrounding vessels in the SR (arrows) and occasionally in the hilus (H) region. (e,f) AQP4
intensity was measured along linear ROIs crossing the lumen of small vessels or cerebral capillaries in WKY and
SHRSP rats and converted into a polarization index (Supplementary Fig. 4 and Methods for more information).
(g) Perivascular AQP4 polarization index of small vessels in the ventral hippocampus is significantly reduced in
SHRSP when compared to WKY rats. (h) In the occipital cortex, the perivascular AQP4 polarization index of
small vessels was also significantly reduced in SHRSP when compared to WKY rats. Scale bar = 250 µm.

in SHRSP rats, corresponding microvascular networks were larger in size and the microvasculature were denser
(Supplementary Fig. 6g–i). We speculate that the microvascular network remodeling might have affected the PVS
transport from the circle of Willis into downstream PVS conduits including MCA. However, more investigations
are needed to fully understand mechanisms underlying the ‘obstructed’ PVS flow in SHRSP rats compared to
WKY rats.

Discussion

Our rOMT Lagrangian workflow method applied to DCE-MRI images of GS transport in whole rat brain provides evidence of both diffusion and advective solute transport modes in the brain parenchyma. First, in normal
brains, rOMT analysis revealed that both advection and diffusion terms were required for pathlines with trajectory speed in the modeled images to resemble GS transport patterns in live brain. Second, particle speed varied
strikingly across tissue compartments with faster solute passage in CSF compared to GM and WM compartments. Third, large differences in regional solute speed within the brain were also documented. Specifically, in
regions close to the ventral surface near large pulsatile arteries (e.g. basal forebrain) solute speed was 2-fold higher
when compared to midbrain and hippocampal regions. Collectively, these novel in vivo results demonstrate that
advective transport is dominating in the non-cellular CSF spaces and that slower diffusion transport contributes
to GS transport as the solute is transferred into parenchyma. Differences in solute speed between CSF and parenchyma can be explained by more restricted transport in the smaller ISF space49 when compared to non-cellular
CSF spaces, given that the solute used in the DCE-MRI studies (Gd-DOTA) is an extracellular tracer. We note
however, that parenchymal GS transport of the extracellular tracer represents transport in ISF (volume fraction
of ~18–22%) as well as the PVS spaces (volume fraction of ~1% or less). Alternative explanations would be less
overall advection as the solute moves away from larger pulsatile pial vessels and/or increased diffusion mode of
solute transport in deeper portions of parenchyma.
The OMT problem was first posed by Gaspard Monge in 178150 and may be formulated as one of transporting one distribution of mass to another in a manner that minimizes a given cost functional. Mass is used in a
general sense and originally referred to soil, as Monge was interested in the civil engineering problem of leveling
the ground. In our work on the GS, mass is represented by signal intensity induced by a paramagnetic contrast
solute (reflecting Gd-DOTA concentrations29) administered into CSF and captured by DCE-MRI. The model is
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related to the Navier-Stokes model but instead of considering momentum, one considers the flow of density51,52.
The advection/diffusion rOMT model is simpler to analyze, but nevertheless provides physically meaningful
information. Interestingly, there are strong connections between rOMT and the porous media and kinetic models
previously applied to characterize GS transport30,40,53. However, in contrast to these models, the rOMT problem
does not require a priori identification or delineation of boundaries, time-varying input or tissue function, or
specification of kinematic parameter values. Other than the assumption of the underlying advection/diffusion
equation, no prior assumptions are imposed on the GS flow. Finally, rOMT may be considered to be an optical
flow technique54, but instead of imposing smoothness on the solutions of the continuity equation, one employs
smoothness as a constraint in minimizing a quadratic energy function.
GS dysfunction is reported in neurodegeneration particularly where vascular dysfunction may be
involved7,38,39. We therefore applied the rOMT framework to dissect modes of solute transport changes in an
animal model of cSVD. cSVD is the major pathology in vascular dementia, and GS dysfunction has recently been
highlighted as a novel pathogenetic factor in cSVD5. The hypothesized link between GS dysfunction and cSVD is
based on the observation of abnormally enlarged PVS in clinical cases of cSVD55. We utilized rOMT analysis to
characterize modes of GS solute transport across tissue compartments in WKY and SHRSP rats. The SHRSP rat
is a naturally bred animal with a parent control strain, which mimics human hypertension and cSVD45. Another
reason that we used the SHRSP rat is that they do not have hydrocephalus – a drawback inherent to other rat
strains with chronic hypertension (e.g. SHR rat56) which may affect CSF flow dynamics7. The rOMT analysis of
DCE-MRI data from the brain showed that the total flux of moving solutes in all tissue compartments (including
CSF) was reduced in SHRSP when compared to normotensive WKY rats.
Interestingly, mean solute speed in the CSF and tissue compartments was not significantly reduced in
SHRSP when compared to WKY rats. However, a separate analysis of CSF transport in the PVS along the MCA
obtained with DCE-MRI acquired with increased spatial resolution and higher contrast-to-noise ratio (increased
Gd-DOTA in CSF) revealed altered CSF flow patterns in SHRSP when compared to WKY rats. In WKY rats,
solute speed along the MCA was homogeneous whereas in SHRSP rats solute flow became overtly heterogeneous
along the MCA. The rOMT analysis of the SHRSP MCA data revealed that solute speed was 3-fold higher at the
MCA-PVS ‘root’ area when compared to speed distal to this area, suggesting a physical or physiological obstruction at this site.
We investigated possible mechanisms underlying the reduced CSF solute flux in specific regions such as
the hippocampus of SHRSP compared to WKY rats. We documented altered perivascular AQP4 expression in
SHRSP compared to WKY rats in hippocampus and occipital cortex which might have contributed to the reduced
GS transport patterns including reduced PVS-to-tissue transfer of solutes. Reduced perivascular expression of
AQP4 water channels has been documented in postmortem human brain with Alzheimer’s disease6 and in aging
rodents39.
In summary, the new rOMT Lagrangian framework analysis introduced here established the presence of diffusion and advective solute transport in brain parenchyma in part supporting the GS hypothesis and its relevance
for waste clearance. In addition, altered solute speed profiles across tissue beds consistent with slower transfer
of solutes from PVS to ISF was revealed in chronic hypertension. Future studies should be conducted to further
optimize the rOMT Lagrangian analysis developed here, and to confirm the observed reductions in solute transport in human cSVD and other neurodegenerative states. In addition, future rOMT work will consist of including
a source term in our set-up to include physical parameters (e.g., pressure) as well as combining OMT with other
metrics, such as Fisher-Rao, in the cost functional to alleviate the explicit constraint of mass preservation in the
model57.

Methods
Animals.

The local institutional animal care and use committees at Yale University, New Haven, USA
approved all animal work. 8-month old WKY female rats and aged-matched female SHRSP rats (Charles River,
Wilmington, MA, USA) were included in the study. Rats were given standard rat chow and water ad libitum. All
methods were performed in accordance with the relevant guidelines and regulations.

Blood pressure measurements in SHRSP and WKY rats.

Non-invasive blood pressure measurements
were performed in a selection of awake WKY and SHRSP rats using tail cuff method (CODA monitor, Kent
Scientific Corporation, USA). Three measurements were taken at 5-min intervals from each rat and the average
of systolic and diastolic pressures were used for the analysis. In a separate series of anesthetized WKY (N = 6) and
SHRSP rats (N = 5), mean arterial blood pressure was measured using a catheter inserted into the femoral artery.
Anesthesia for these rats was performed with isoflurane and dexmedetomidine as described below.

Anesthesia and cisterna magna catheter. For all glymphatic experiments, rats were anesthetized with
3% isoflurane delivered into an induction chamber in 100% O2 and after loss of the righting reflex received dexmedetomidine (0.015 mg/kg i.p.) and glycopyrrolate (0.2 mg/kg i.p.). Surgical anesthesia was maintained with
2–2.5% isoflurane and the rats were breathing spontaneously throughout the experiments. A small 5-mm copper
tube (0.32 mm o.d., Nippon Tockushukan, MFG. CO., LTD, Tokyo, Japan) attached to a PE-10 microcatheter was
implanted into the CSF via the cisterna magna and secured in place using cyanoacrylate glue. Following surgery,
the rats were transferred to the MRI instrument. Anesthesia was maintained throughout the experiment by 0.5–
1.0% isoflurane in 1:1 Air:O2 mixture delivered via a nose cone, and a subcutaneous infusion of dexmedetomidine
(0.015–0.020 mg/kg/hr)58. During imaging, respiratory rate, oxygen saturation, body temperature and heart rate
were continuously monitored using an MRI compatible monitoring system (SA Instruments, Stony Brook, NY,
USA). Body temperature was kept within a range of 36.5 °C–37.5 °C using a heated waterbed.
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MRI imaging. All MRI acquisitions were performed on a Bruker 9.4 T/16 magnet (Bruker BioSpin, Billerica

MA) interfaced to an Avance III console controlled by Paravision 6.0 software. All rats were imaged in the supine
position. For the whole-brain glymphatic experiments, we used a 3-cm planar receive surface radio-frequency
(RF) coil (Bruker) which was positioned under the head of the rat with a separate preamplifier used as a receiver.
For rats where glymphatic transport was explored along the middle cerebral artery, a 1-cm planar RF coil (Bruker)
was placed above the left side of the rat’s head. A custom-made volume diameter volume coil (50-mm i.d.) was
used as a transmit RF coil.

DCE-MRI for GS transport. Following an anatomical localizer scan, acquisition of the DCE-MRI started
using a VFA-SPGR sequence. For whole brain glymphatics studies: TR (repetition time) = 25 msec, TE (echo
time) = 4 msec, 0.30 × 0.30 × 0.30 mm FA (flip angle) = 15°, number of averages = 2, Time/scan = 5 min). For
the MCA glymphatics studies (left hemisphere): TR = 25 msec, TE = 4 msec, 0.15 × 0.15 × 0.15 mm FA = 20°,
number of averages = 1, scan time = 4 min 10 s). A reference phantom filled with 0.1 mM Gd-DOTA was placed
in the field of view to allow both intensity normalization between each scan and receiver gain adjustment. For
measurement of GS transport, DCE-MRI were acquired before (3 baseline scans), during, and after the infusion
of gadoteric acid (Gd-DOTA, DOTAREM, Guerbert LLC, Carol Stream IL) into the CSF via the CM catheter30.
Specifically, for whole brain studies we infused Gd-DOTA (0.5 mmol/ml) in a 1:37 dilution: 1-part Gd-DOTA
(0.5 mmol/ml):18-parts of sterile water:18-parts of 0.9% saline. This Gd-DOTA solution has a density of approximate 1.005 g/ml, which is isobaric with respect to CSF (CSF specific gravity = 1.004–1.007). The solution was
infused at a constant rate of 1.5 µL/min and a total volume of 20 µl was infused. Intracranial pressure in the CM
was measured in separate rats positioned in a stereotaxic frame under the same anesthesia regimen and with
physiological parameters similar to those of rats undergoing glymphatic transport inside the MRI. The ICP was
4–5 mmHg prior to infusion and increased by ~1 mmHg during infusion. For the higher resolution MCA scans,
we infused 20 µL, of 1:5 Gd-DOTA diluted with sterile water at a rate of 1.5 µL/min.
Morphometry for segmentation of tissue compartments and ROI. To study tissue compartment
specific glymphatic transport, WKY (N = 7, 8-months old) and SHRSP (N = 7, 8-months old) rats were scanned
using the 3D VFA-SPGR sequence (TR/TE/FA/number of averages = 15 ms/4 ms/5~30°/2 scanning time = 30 min
0.30 × 0.30 × 0.30 mm3) as described previously4,56. Proton density weighted images calculated from VFA-SPGR
were segmented using a custom made SHRSP-WKY rat brain template in deriving spatial registration parameters4. Spatially normalized segmented images were population averaged and thresholded (0.5) to create a population averaged binary mask for GM, WM and CSF, and inverse warped to match the individual rat brain. The
GM, WM and CSF compartments were carefully segmented based on the pre-contrast images. CSF compartment contains PVS associated with pial vessels on the surface of the brain. However, the outer boundaries of the
GM mask excluded pial vessels on the brain surface and therefore also PVS associated with pial vasculature. We
also carefully avoided including large veins such as the strait sinus, transverse and sagittal sinuses. We note that
the PVS associated with smaller vasculature inside GM and WM masks are unavoidably included, but as mentioned represents only a minor volume fraction (< 1–2% in normal brain) when compared to the ISF fluid space
(18–22%). To study ROI specific glymphatic transport, the publicly available Waxholm Wistar rat brain atlas59
was downloaded, and ROIs in the atlas were warped onto the individual SHRSP-WKY rat brains in two steps.
First, the high resolution T2 weighted Waxholm Wistar rat brain atlas was segmented using the SHRSP-WKY
template to derive the registration parameters between the atlas and the SHRSP-WKY template. The registration
parameters were then applied onto the ROIs to construct the ROIs in the template space. ROIs in the template
space were then inverse warped, which was derived from the tissue compartment analyses, to create the ROIs in
the individual brain. Nineteen regions were included in the atlas: anterior commissure, basal forebrain region,
brainstem, hippocampus, corpus callosum, descending corticofugal pathway, fimbria of hippocampus, hypothalamus, superior colliculus, cerebellum, cortex, olfactory bulb, penial, periaqueductal grey, septal region, striatum,
subiculum, substantia nigra and thalamus. Only four of these (basal forebrain, cerebellum hippocampus and
superior colliculus) were used for GS analysis purposes.
rOMT analysis of DCE-MRI data. In the next few sections, we provide the necessary details pertaining to
our regularized OMT framework before describing how it was utilized for analyzing the DCE-MRI data.

Regularized OMT (eulerian framework)

The regularized OMT (rOMT) problem60 considers the minimization of the energy functional
[µ , v] =

1

∫0 ∫
X

1
µ(t , x )||v(t , x )||2 dxdt
2

(1)
n

overall time-varying densities µ = µ(t , x ) ≥ 0 and sufficiently smooth velocity fields v = v(t , x ) ∈  subject
to the advection/diffusion (constraint) equation
∂tµ + ∇ ⋅ (µv ) = ∇ ⋅ (D∇µ),

(2)

n

for all x ∈ X, a connected Euclidean subdomain of  , over the normalized time interval t ∈ [0, 1] with initial
and final conditions
µ(0, x ) = µinit (x ), µ(1, x ) = µfinal (x ), ∀ x ∈ X.
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Here, µinit and µfinal are given observed states of the density at respective times t = 0 and t = 1, and Ddenotes
a symmetric positive definite diffusivity matrix, which may be spatially dependent or independent. When D = 0,
the constraint (2) is simply the advection equation and we recover the classical dynamic-OMT formulation37.
From the Calculus of Variations37,60, the Euler-Lagrange equations associated with the regularized OMT problem (Eqs. (1–3)) shows that the optimal velocity, vopt , has the form
vopt = −∇η,

(4)

where η is the Lagrange multiplier of constraints (2 and 3) and satisfies the diffusion Hamilton-Jacobi equation,
∂tη −

1
||∇η||2 = ∇ ⋅ D∇η.
2

(5)

The diffusion term plays a dual role. First of all, it regularizes the flow. In fact, it makes the problem equivalent to the so-called Schrödinger bridge problem, and therefore to a certain type of regularization (related to
Fisher information) of the cost function37,60. This leads to smoother flow fields. Secondly, it captures a key feature in modelling the underlying dynamics that may best be understood via compartmental models that will be
described in the next section.

Regularized OMT and compartmental models.

Compartmental models61 are comparable to spatially
averaging the regularized OMT continuity Eq. (2). More precisely, one may average the continuity equation by
integrating it over a control volume (i.e., compartment) C:

∫ ∂tµ dC + ∫ ∇ ⋅ (µv) dC = ∫ ∇ ⋅ (D∇µ) dC.
C

C

C

(6)

Considering the advective term, we see that

∫ ∇ ⋅ (µv) dC = ∫ µv ⋅
C

→
n dB = −

B

∫ µ ∇η ⋅
B

→
n dB

(7)

n is the unit outward normal of B, the compartment boundary. In this
by (4) and the divergence theorem, where →
form, the OMT-advection may be interpreted as an expression of Darcy’s law, which relates flow velocity to the
pressure gradient, as used in the porous media model. We note that the OMT-velocity does not explicitly account
for pressure differences while the porous-media-velocity does. One can supplement a pressure dependent source
term in the continuity equation, an extension we plan to explore in future work. Considering the unresolved true
physical parameter values, this exemplifies the OMT framework’s utility for capturing, representing and informing on meaningful dynamic behavior implicitly encoded in the given observed density distributions, along with
interesting insight into how the method works.
Applying the divergence theorem to the diffusive term we find:

∫ ∇ ⋅ (D∇µ) dC = ∫ D∇µ ⋅
C

→
n dB ,

B

(8)

and thus, we see that diffusion is influenced by the density gradient, in accordance with Fick’s law. Noting that the
total mass in C at time t is given by

 (t ): =

∫ µ dC,

(9)

C

the averaged form of the diffusion-OMT constraint over the given compartment C relates the change in its density
over time to the flux across its boundary, and (6) may be written as
d
 (t ) =
dt

∫ ( D∇ µ − µ v ) ⋅
B

→
n.

(10)

Here, jAD = − (D∇µ − µv ) is the total flux, comprised of both advective and diffusive components. We note
that the two are not independent of each other, as is seen by (5).
To illustrate the compartmental regularized OMT formulation, we compare tracer movement from CSF into
the tissue compartment between normotensive (WKY) and hypertensive (SHRSP) cases. As such, we take the
tissue compartment to be our control volume C and consider the surface boundary B between the CSF and tissue
compartment (Supplementary Fig. 3a). For every boundary point x ∈ B, we can define the unit normal vector
→
n points from the CSF compartment
n (x ) that is orthogonal to the surface at x and we orient the surface so that →
into the tissue compartment (Supplementary Fig. 3b). Using the OMT-derived velocity field and smooth images,
we can then look at the total (advective + diffusive) flux jAD across this surface at each time step by considering
the component of the flux in the normal direction. At a given time, (10) describes the net mass flowing through
the surface. However, we are specifically interested in the net mass that moves from the CSF compartment into the
tissue compartment. We are therefore interested in the normal component of the flux such that jAD ⋅ →
n > 0. Due
to the directional information provided by the rOMT, this can be readily be determined. Fluctuations in
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voxel-level information given by rOMT are clearly lost when averaged, indicative of the well-known challenge for
the kinetic analysis approach for local insight.

Regularized OMT-lagrangian framework. The Eulerian framework records measurements at fixed locations for multiple points in time, informing on the collective instantaneous behavior of the flow. We now describe
our Lagrangian framework for expressing the trajectories of fixed parcels or particles. In this work we have
assumed that the diffusion is constant, D = σ 2I . While this assumption is somewhat restrictive, it nevertheless
gives physically meaningful results. All the theory goes through in the non-constant spatially dependent setting.
In future work, we plan to examine this extension in more detail. We note that
∇ ⋅ (µv ) − ∇ ⋅ (σ 2∇µ) = ∇ ⋅ (µv ) − σ 2∇ ⋅ (µ∇ log µ)

(11)

=∇ ⋅ [µ(v − σ 2∇ log µ)] .

(12)

v aug : = v − σ 2∇ log µ ,

(13)

Defining the augmented velocity

we derive the conservation form of the regularized constraint (2),
∂tµ + ∇ ⋅ (µv aug ) = 0 .

(14)

The Lagrangian coordinates L = L(t , x ) of the optimal trajectory for the regularized OMT system are given by
aug
∂tL = vopt
(t , L(t , x ), L(0, x ) = x ,

(15)

aug
vopt
= vopt − σ 2∇ log µopt ,

(16)

where

and vopt and µopt denote the optimal arguments of the regularized OMT problem (1–3).

Numerical regularized OMT model for glymphatic system. In this section, we discuss the consider-

ations taken for applying the regularized OMT model to the glymphatic system and its numerical implementation. For our purposes, MR signal enhancement induced by Gd-DOTA is treated as density (the relationship
between mass and signal enhancement has been previously validated62). The images then provide discrete observations µinit and µfinal of the tracer distribution at some initial time t = 0 and a final time t = 1, respectively. Space
is discretized as a cell-centered grid of size m1 × m2 × m3 with a total number of M cells, each with uniform
length dx , as delineated by the voxels. Time is split into n intervals of length dt and the N + 1 time steps are
denoted by the subscript n where n = 0 corresponds to the time t = 0, n = N corresponds to the time t = 1 and
T
T
dt ∗ N = 1. Bold font is used to denote linearized variables and we use µ = [µ 0T , … , µNT ] , v = [v1T , … , vNT ] to
represent the temporal concatenation of the linearized densities and velocities, respectively. Note that vn is the
velocity field that describes the evolution between µn −1 and µn subject to the advection/diffusion Eq. (2), for
n = 1, … , N .
Following the work of Steklova and Haber63, the numerical method used here was chosen for its nice properties for differentiating and optimizing the resulting discrete regularized OMT problem, which will become clear
in the discussion to follow.
We start by discretizing the advection/diffusion Eq. (2) as
(IM − dtD)µn +1 = A(vn)µn , n = 0, … , N − 1,

(17)

where Is is the s × s identity matrix, D is the discrete diffusion operator ∇ ⋅ D∇ and A is an averaging matrix that
assigns the density of the advected particle in space to the cell centers. This is derived via operator splitting where
the advective step is performed using a particle-in-cell method and the backward Euler method is used for the
diffusive step, see Steklova and Haber63 for more details. Notice, the density for any time step now depends only
on the velocity v and initial density µ 0. Considering that the initial density is fixed by the given image µ 0 = µ init ,
we have reduced the parameter space of our objective cost functional (1), so that we only need find the optimal
velocity.
A straightforward discretization of the OMT energy functional [v] (1) (as just noted we ignore the density
term) is given as
[v] : = dt(dx )3 µT (IN ⊗ [IM IM IM])(v  v ),

(18)

where ⊗ denotes the Kronecker product, [ ⋅|⋅ ] denotes block matrices and  denotes the Hadamard product. We
seek the velocity v that characterizes the density µ which interpolates between the given initial and final densities,
µ init and µ final , seen to evolve according to the advection/diffusion Eq. (17) with minimal energy, as described by
the discrete objection function [v] (18). Lastly, in anticipation of noise in the signal intensity, we do not attempt
to match the final density exactly (3). Instead, we explicitly regard the final image as a noisy state of the tracer
distribution
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Symbol

Interpretation

µinit

initial observed density

µ final

final observed density

µ

noise-free density

v

velocity

ψ

independent, identically distributed Gaussian noise with covariance Ψ

X

spatial domain

x

spatial variable

t

temporal variable

D

symmetric positive definite diffusivity matrix

σ2

diffusivity coefficient

η

Lagrange multiplier associated with the regularized OMT problem

C

control volume (i.e. compartment)

B
→
n

boundary of control volume C

jAD

total (advective + diffusive) flux

unit outward normal vector of boundary B

v aug

augmented velocity

L = L(t , x )

Lagrangian coordinates of optimal trajectory

Table 1. Symbol reference list.

µN + ψ = µfinal

(19)

where ψ is independent, identically distributed Gaussian noise with covariance Ψ, treated as a free temporal endpoint of the partial differential equation. As such, the discrete regularized OMT problem is given as
inf [v] + ξ||µN − µ final ||2Ψ

(20)

{(IM − dtD)µn +1 = A(vn)µn , n = 0, … , N − 1

(21)

{µ 0 = µ init .

(22)

{µ ≥ 0

(23)

such that

Here, the free-endpoint condition added to the objective function (20) inhibits the erroneous influence of
noise on the velocity, inversely weighted by the covariance and the parameter ξ indicates the relative significance
of fitting the data to minimizing the transport energy.
Using no diffusion or too small of a diffusion value yields implausible results (e.g. non-smooth velocity fields
due to overcompensation by advection which therefore cannot reflect proper trajectories), but too large a value
will have an accumulated effect that may end up over-smoothing the images over time (e.g. intensity gradients
will be blurred yielding fictitious advective behavior attempting to reverse the spreading and subtler information
will be lost). Multiple levels of diffusion were tested to determine values that afforded an appropriate balance. We
note that for small changes in diffusion values (i.e. changes of the same order of magnitude), we found the model
to be robust to the diffusivity. The aforementioned implausible behavior was only observed when the magnitude
of the diffusivity was changed by an order of 2 or more, as expected. One would expect that increasing diffusion
in a system of diffuse particles would allow for more random or unexpected behavior to occur. In this manner,
diffusion allows for a natural description of stochastic particle trajectories thereby regularizing the flow.
Accordingly, adding the diffusion term to the classical OMT constraint enables our model to account for more
behavior than would be possible with advection alone. We therefore refer to our system of Eqs. (20–23) as the free
regularized OMT problem (frOMT), used interchangeably with rOMT), which turns out to be a quadratic optimization problem with linear constraints with respect to v . The optimal velocity and interpolated densities are then
found using a Gauss-Newton method. See Table 1 for a list of symbols and their interpretations.

rOMT data analysis. Image processing of the series of DCE-MRI data of each rat consisted of head motion

correction, intensity normalization, smoothing, and voxel-by-voxel conversion to percentage of baseline signal
using SPM1264,65 (https://www.fil.ion.ucl.ac.uk/spm/). The processed images were converted into NIfTI format
for further analysis. DCE-MRI images were fed as inputs into our rOMT model in order to capture advective
and diffusive transport in different compartments including CSF spaces, grey matter (GM), white matter (WM),
brain regions (and PVS) along the MCA. Unless otherwise specified, all computation was carried out in MATLAB
(Version 2016b). The rOMT procedure was run in parallel on all 14 whole brain datasets (8 WKY, 6 SHRSP) on
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the SeaWulf (Stony Brook University) CPU cluster (with a total of 4592 nodes and 128 gigabytes RAM per node)
to model a 120 min time period of tracer transport captured across 21 images, which took approximately 52 hours
to execute. We note that fewer interpolated time steps could have been used to achieve a shorter runtime, but we
felt a thorough investigation warranted the extended time. rOMT was performed on the 8 higher resolution MCA
datasets (4 WKY and 4 SHRSP) in the same manner over a time period of 144 min captured across 25 images with
a total runtime of approximately 66 hrs. More time was required due to the longer time period being considered
and decreased signal-to-noise ratio. Again, fewer intermediate steps could be used with minimal differences in
output for future applications.
We used the Lagrangian OMT formulation (vide supra) to construct the pathlines for visualizing GS transport
flows over the 120 min time period in one comprehensive figure, derived from the rOMT returned velocity field
and interpolated images. In order to extract and visualize trajectories from 4D data in a meaningful way, the
several steps were performed on each dataset. First, pathline start points were selected uniformly among voxels
that showed at least 12% increase in signal as compared to baseline throughout the imaging acquisition interval.
This was done in order to reduce the complexity of the visualization, as the trajectory of a parcel from a location
with such low fluctuation may be attributed to noise or insignificant behavior. Pathlines were then parametrized
by the Lagrangian coordinates (21) associated with each start point and were computed by integrating the augmented time-varying velocity field (19), as described above. Particle attributes such as speed, informing on the
state of the particle along its trajectory, were simultaneously recorded and referred to as speed-lines. The pathlines
were subsequently clustered by spatial proximity using the QuickBundles algorithm66 in Python (Version 3.5.4),
and pathlines of small clusters deemed ‘insignificant’, as determined by a predefined threshold, were removed
from consideration. ‘Significant’ pathlines were then converted back from spatial coordinates to the cell centered
grid using a tri-linear averaging matrix and saved in nifti format for visualization in Amira. Runtime for the
Lagrangian procedure is ~3 min per dataset on a standard laptop with a 2.2 GHz Intel Core i7 processor.
Time-varying particle attributes associated with the pathlines, such as speed and density, provide more
detailed information regarding the particle dynamics. We selectively focused on the speed for the novel insight
it provides. Specifically, speeds that make up the aforementioned speedlines were computed as the magnitudes
of the rOMT-derived transport vectors ascribed to the time and place of each point along the particle’s path and
then visualized to analyze speed trajectories in different brain regions and across normotensive and hypertensive
states.
For each rat, we computed one Lagrangian rOMT image reflecting pathlines and one reflecting pathline speed
(i.e. speedlines), at a voxel resolution of 0.3 × 0.3 × 0.3 for whole brain and 0.15 × 0.15 × 0.15 mm3 for hemispheric data. For the whole brain data, total pathline volume and mean pathline speed were extracted from CSF,
GM, WM and four predetermined brain regions (basal forebrain, superior colliculus, hippocampus and cerebellum). For MCA data, pathline volume and mean pathline speed were extracted in regions along the MCA
segment on the base of the brain (a.k.a. MCA ‘root’) and along the left MCA.

Immunohistochemistry. Animals were deeply anesthetized with ketamine/dexmedetomidine
(150 mg kg−1/2 mg kg−1 i.p) and were transcardially perfused with phosphate buffered saline (PBS) followed by
paraformaldehyde (PFA; 4% in PBS). The brains were extracted, post-fixed overnight in PFA at 4 °C and transferred to PBS. All incubations were carried out at room temperature unless specified. Brains were sectioned coronally (50 µm) with a vibratome (Leica VT1000 S) and underwent heat-induced epitope retrieval in citrate buffer
(10 mM citric acid, 0.05% Tween 20, pH 6.0) at 85 °C for 30 min. The sections were then blocked and permeabilized for 1.5 h (1% BSA, 1% normal goat serum, and 0.3% Triton) and incubated for 2 h at 25 °C with primary
antibodies: rabbit anti-AQP4 (Novus, NBP1–87679, 1:500) and chicken anti-GFAP (Abcam, ab4674, 1:1000) in
PBS, 0.05% Tween 20, and 1% BSA. Following this, sections were incubated for 2 h at 25 °C with Alexa Fluor-Plus
goat anti-rabbit 555 and Alexa Fluor goat anti-chicken 647 secondary antibodies (Invitrogen, 1:1000) in PBS with
0.05% Tween 20. The sections were then mounted on slides and cover slipped.
The MCA brains were also processed for GFAP, AQP4 and collagen IV. The PFA fixed brains were cryoprotected in 30% (w/v) sucrose in PBS, embedded in O.C.T. compound and snap-frozen at −80 °C. Sections were
cut coronally (20 µm) using a cryostat, mounted on Colorfrost/Plus slides and stored at −80 °C. The sections
were rehydrated in PBS, incubated with proteinase K for 15 min (0.2 mg/ml) and incubated in blocking buffer
for 30 min (0.3% Triton in SuperBlock buffer). The sections were then incubated overnight at 4 °C with primary
antibodies: goat anti-collagen IV (Novus, NBP-126549,1:200), rabbit anti-GFAP (Dako, Z0334, 1:250), rabbit
anti-AQP4 (Novus, NBP-1-87679) and goat anti-Iba-1 (Novus, NBP-100-1028, 1:250). The next day, sections
were incubated with Alexa Fluor 594 or 488 secondary antibodies (Invitrogen, 1:1000). The sections were then
cover slipped and sealed. Images were captured using a Keyence fluorescence microscope BZ-X700 system.
Quantification of AQP4 polarization. Images of AQP4 immunofluorescence were captured on a Keyence
BZ-X700 automated fluorescence microscope using 4–20 × air objectives as z-stack tile-scans with 3 µm z-steps in
maximum contrast projections. Quantification of AQP4 polarization was done in the ventral hippocampus and
occipital cortex using ImageJ software (Image J 1.52i). The AQP4 digitized images were imported into ImageJ,
scaled and converted to optical density images. In order to unbias the analysis, a grid (150 numbered boxes)
was overlaid over the ventral hippocampus (each box area = 228 × 228 pixels) and occipital cortex (each box
area = 282 × 282 pixels). 15 boxes from hippocampal or cortical sections were randomly selected for a total of ~30
small vessels and ~30 capillaries for WKY rats and the same number of vessels in SHRSP rats. Representative line
segments (300 µm for small vessels and 100 µm for capillaries) were used to extract immuno-intensity across the
micro-vessels selected in each grid-box. The polarization index for each vessel was calculated (peak-to-baseline
level).
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Quantification of GFAP and AQP4 mRNA by real-time quantitative RT-PCR (qPCR). Astrogliosis

and AQP4 water channel expression were evaluated in the brains of WKY and SHRSP rats suing real-time quantitative RT-PCR (qPCR). Specifically, for this purpose, mRNA levels of the two targets (GFAP and AQP4) by
qPCR was performed with the QuantStudio 3 Real-Time PCR system (Applied Biosystems). Brain tissues of
interest (WKY, N = 8; SHRSP, N = 8) were quickly dissected, snap frozen in liquid nitrogen and stored at −80 °C.
Total RNA extraction was carried out using the PARIS kit (Invitrogen) following brief homogenization using
the TissueRuptor II (Qiagen). Total RNA concentrations were measured using the SpectraMax i3x Multi-Mode
microplate reader (Molecular Devices). Samples were then treated with ezDNase enzyme (Invitrogen) to degrade
any genomic DNA and subsequently reverse transcribed to cDNA using the Superscipt IV VILO kit (Invitrogen).
Quantification of target mRNA was performed using TaqMan gene expression assays (ThermoFisher Scientific).
The PCR cycle parameters were set according to the recommended guidelines for the TaqMan Fast Advanced
Master Mix (Applied Biosystems), which was used to run the qPCR reactions (95 °C for 2 min [polymerase activation] followed by 40 cycles of 95 °C for 1 s [denture] and 60 °C for 20 s [anneal/extend]). TaqMan primer/probe
sets for AQP4 (Rn00563196_m1) and GFAP (Rn00566603_m1) were used. mRNA target signals were normalized
to the housekeeping gene RPLP0 (Rn00821065_g1). Relative fold change values were calculated using the 2−ΔΔCt
method67. The mRNA target signals were first normalized to the reference housekeeping gene RPLP0. Following
this, relative fold change values were calculated using the 2−ΔΔCt method by normalizing the data to the cerebellum, which was used a reference region.

Statistical information. Group sizes for the whole brain glymphatics studies were estimated based on pre-

vious studies40,58. For peak magnitude point comparisons, group sample sizes of 6 (WKY) and 6 (SHRSP) achieve
80% power to detect a Cohen’s effect size of 2.0, and with a significance level (α) of 0.025 using a two-sided
two-sample unequal-variance t-test. All data are presented as mean ± SD. If data showed normal distribution, a
paired or unpaired Student’s t-test was used to compare groups. When data lacked normal distribution, groups
were compared using non-parametric testing (Mann-Whitney test for unpaired comparison, Wilcoxon signed
rank test for paired comparisons). For within-group regional differences Friedman’s ANOVA was used. All testing
was two-tailed and exact P values were calculated at a 0.05 level of significance and stated in the figure legends.
Blinding for data analysis was done where possible. All statistical analyses were performed using XLSTAT statistical and data analysis solution (Addinsoft (2019). XLSTAT statistical and data analysis solution. Boston, USA.
https://www.xlstat.com) or GraphPad Prism 7 (GraphPad Software).
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